Advancing strategies for valvular heart disease and pulmonary hypertension: insights and perspectives

被引：0
|
作者：
Lancellotti, Patrizio [1 ]
Dulgheru, Raluca [1 ]
机构：
[1] Univ Liege Hosp, Dept Cardiol, GIGA Cardiovasc Sci, Liege, Belgium
来源：
ACTA CARDIOLOGICA | 2024年 / 79卷 / 09期
关键词：
D O I：
10.1080/00015385.2024.2436769
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：973 / 977
页数：5
相关论文
共 50 条
  • [21] PULMONARY INVOLVEMENT IN VALVULAR HEART-DISEASE
    SCHLICK, W
    MORITZ, A
    KLEPETKO, W
    SCHOFL, R
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S1 - S1
  • [22] DECADE IN REVIEW-VALVULAR DISEASE Current perspectives on treatment of valvular heart disease
    Mohr, Friedrich W.
    NATURE REVIEWS CARDIOLOGY, 2014, 11 (11) : 637 - 638
  • [23] Current Treatment Strategies in Pulmonary Hypertension Associated with Left Heart Disease
    Selby V.N.
    De Marco T.
    Current Transplantation Reports, 2015, 2 (4) : 345 - 354
  • [24] Pulmonary hypertension and left heart disease: emerging concepts and treatment strategies
    O'Callaghan, D. S.
    McNeil, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 : 29 - 31
  • [25] Management of Pulmonary Hypertension Secondary to Valvular Heart Disease with Angiotensin-Receptor Neprilysin Inhibitor
    Ali, H. R.
    Thomas, J.
    Guha, A. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S200 - S200
  • [26] ECHOCONTRAST STUDIES OF THE RIGHT HEART CHAMBERS IN PATIENTS WITH ACQUIRED VALVULAR DISEASE AND PULMONARY-HYPERTENSION
    LAUCEVICIUS, A
    GEFENAS, E
    MISIURA, J
    PALIUSCINSKAJA, N
    KAVOLIUNAS, D
    KANTAROVIC, E
    KARDIOLOGIYA, 1987, 27 (04) : 35 - 40
  • [27] Pioneering the impact of sildenafil on intraoperative and survival in pulmonary hypertension with valvular heart disease: A pilot study
    Ghaffar, F. abdul
    Redzuan, A. md
    Makmor-bakry, M.
    Nor, M. a muhamad
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [28] Stress echocardiography for evaluation of hemodynamics: Valvular heart disease, prosthetic valve function, and pulmonary hypertension
    Bach, DS
    PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 39 (06) : 543 - 554
  • [29] Management of pulmonary hypertension associated with valvular heart disease with angiotensin-receptor neprilysin inhibitor
    Ali, Hyeon-Ju Ryoo
    Thomas, Jerome
    Sahay, Sandeep
    Guha, Ashrith
    PULMONARY CIRCULATION, 2023, 13 (04)
  • [30] Primary pulmonary hypertension, valvular heart disease and fenfluramine use? Hypothesis or certitudes? Legend or reality?
    Godeau, P
    Cherin, P
    Tellier, P
    REVUE DE MEDECINE INTERNE, 1998, 19 (10): : 700 - 703
12345